Stoke Therapeutics saw the highest growth of 0.99% in patent filings in May and 0.32% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.74% and grants by 0.32%. GlobalData’s DataBook provides a comprehensive analysis of Stoke Therapeutics’s patent filings and grants. Buy the databook here.
Stoke Therapeutics has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 33% of filings. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Hungary(HU) patent Office are among the top ten patent offices where Stoke Therapeutics is filings its patents. Among the top granted patent authorities, Stoke Therapeutics has 100% of its grants in Spain(ES).
Roche and Ionis Pharmaceuticals could be the strongest competitors for Stoke Therapeutics
Patents related to genomics and rare diseases lead Stoke Therapeutics's portfolio
Stoke Therapeutics has the highest number of patents in genomics followed by, rare diseases. For genomics, nearly 67% of patents were filed and 100% of patents were granted in Q2 2024.
Epilepsy related patents lead Stoke Therapeutics portfolio followed by dravet syndrome (severe myoclonic epilepsy of infancy), and lennox-gastaut syndrome
Stoke Therapeutics has highest number of patents in epilepsy followed by dravet syndrome (severe myoclonic epilepsy of infancy), lennox-gastaut syndrome, epileptic encephalopathy, and febrile seizures. For epilepsy, nearly 12% of patents were filed and 14% of patents were granted in Q2 2024.
For comprehensive analysis of Stoke Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.